欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子抑制剂 > Apoptosis > (R)​-​CR8

浏览历史

S87699

(R)​-​CR8

源叶(MedMol) 98%
  • 英文名:
  • (R)​-​CR8
  • 别名:
  • CR8, (R)-Isomer
  • CAS号:
  • 294646-77-8
  • 分子式:
  • C₂₄H₂₉N₇O
  • 分子量:
  • 431.53
  • 核磁/质谱:
品牌货号产品规格价格(RMB) 库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
源叶(MedMol) S87699-5mg 98% ¥720.00元 6 0 0 0 EA 加入购物车
源叶(MedMol) S87699-10mg 98% ¥1120.00元 5 0 0 0 EA 加入购物车
源叶(MedMol) S87699-25mg 98% ¥2320.00元 4 0 0 0 EA 加入购物车
源叶(MedMol) S87699-100mg 98% ¥7200.00元 预计交期:2-3天 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 产品描述: (R)​-​CR8 (CR8), a second-generation analog of Roscovitine, is a potent CDK1/2/5/7/9 inhibitor. (R)​-​CR8 inhibits CDK1/cyclin B (IC50=0.09 μM), CDK2/cyclin A (0.072 μM), CDK2/cyclin E (0.041 μM), CDK5/p25 (0.11 μM), CDK7/cyclin H (1.1 μM), CDK9/cyclin T (0.18 μM) and CK1δ/ε (0.4 μM). (R)​-​CR8 induces apoptosis and has neuroprotective effect. (R)-CR8 acts as a molecular glue degrader that depletes cyclin K
  • 靶点: Cdk1/cyclin B:0.09 μM (IC50);cdk2/cyclin A:0.072 μM (IC50);CDK2/cyclinE:0.041 μM (IC50);Cdk5/p25:0.11 μM (IC50);CDK7/cyclin H:1.1 μM (IC50);CDK9/Cyclin T:0.18 μM (IC50);CK1δ/ε:0.4 μM (IC50);Apoptosis; CDK
  • 体外研究:
    (R)-CR8 (CR8) (0.1-100 μM; 48 hours) is a potent inducer of apoptotic cell death with an IC50 of 0.49 μM for SH-SY5Y cell line. (R)-CR8 (0.25-10 μM) induces a dose-dependent induction of poly-(ADP-ribose)polymerase (PARP) cleavage. The CDK-bound form of (R)-CR8 has a solvent-exposed pyridyl moiety that induces the formation of a complex between CDK12-cyclin K and the CUL4 adaptor protein DDB1, bypassing the requirement for a substrate receptor and presenting cyclin K for ubiquitination and degradation. Apoptosis Analysis Cell Line: SH-SY5Y cell line Concentration: 0.1, 1, 10, 100 μM Incubation Time: 24 hours Result: Reduced cell survival in a dose-dependent manner.
  • 体内研究:
    (R)-CR8 (5 mg/Kg; i.p.) results in a significant reduction in lesion size at 28 days in histological assessment. Animal Model: Adult (10 to 12 weeks old) male Sprague-Dawley rats (310 to 330 g)[2] Dosage: i.p. Administration: 5 mg/Kg Result: Resulted in a significant reduction in lesion size.
  • 参考文献:
    1. Bettayeb K, et al. CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases. Oncogene. 2008 Oct 2;27(44):5797-807. 2. Kabadi SV, et al. CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury. J Cereb Blood Flow Metab. 2014 Mar;34(3):502-13. 3. Słabicki M, et al. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K [published online ahead of print, 2020 Jun 3]. Nature. 2020;10.1038/s41586-020-2374-x.
  • 溶解性: Soluble  in  DMSO
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.317 ml 11.587 ml 23.173 ml
    5 mM 0.463 ml 2.317 ml 4.635 ml
    10 mM 0.232 ml 1.159 ml 2.317 ml
    50 mM 0.046 ml 0.232 ml 0.463 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。